The LigaSure™ Maryland jaw thoracic sealer/divider is part of our commitment to transforming lung care.
It’s the first — and only — minimally invasive LigaSure™ device designed for VATS procedures and indicated for sealing pulmonary veins and arteries up to and including 7 mm.1–5,([FOOTNOTE=Based on internal report #RE00147462, Pulmonary sealing claims for the LigaSure™ LF1930T device (memo). March 29, 2018.],[ANCHOR=],[LINK=])
The multifunctional LigaSure™ Maryland jaw thoracic device complements thoracic procedures by providing:
Reliable LigaSure™ vessel-sealing technology drives the LigaSure™ thoracic device. It works by using the body’s own collagen and elastin to create a permanent seal that is designed to withstand three times normal pulmonary systolic blood pressure.3
Plus, LigaSure™ technology eliminates the guesswork — and minimizes thermal spread8,([FOOTNOTE=Based on internal report # R0047634_A, Comparison of various competitor devices versus the Sonicision™ device and LigaSure™ LF1637 and LF1737 devices; acute porcine study. Nov. 11 and 18, 2013, and Dec. 9, 2013.],[ANCHOR=],[LINK=]),‡ — by automatically discontinuing energy delivery when the seal cycle is complete.([FOOTNOTE=Based on internal test report #RE00025819 rev A, LigaSure™ device data sources for VLFT10 white papers. September 2015.],[ANCHOR=],[LINK=])
Get detailed technical and competitive information on our newest LigaSure™ device.
Learn how the LigaSure™ Maryland jaw thoracic sealer/divider compares to our original LigaSure™ Maryland jaw device.
See how our proprietary nano-coating technology enhances the performance of the LigaSure™ Maryland jaw device.
† 31 of 33 surgeons surveyed after use agreed. Compared to straight jaws.
‡ Based on systemic vasculature. Compared to Olympus Thunderbeat™*.